Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,001 | 0,037 | 15:18 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
28.11.23 | Wesana Health Holdings Inc: Wesana agrees to restructuring of note issued by APS | 4 | Stockwatch | ||
28.11.23 | Wesana Health Holdings Inc.: Wesana Health Announces Restructuring of Promissory Note Receivable | 617 | Newsfile | Chicago, Illinois and Toronto, Ontario--(Newsfile Corp. - November 28, 2023) - Wesana Health Holdings Inc. (CSE: WESA.X) (OTCQB: WSNAF) (the "Company"), announced the execution of a Confidential Settlement... ► Artikel lesen | |
11.07.23 | CSE Bulletin: Symbol Change - Inactive Designation - Wesana Health Holdings Inc. (WESA) | 354 | Newsfile | Toronto, Ontario--(Newsfile Corp. - Le 11 juillet/July 2023) - The Exchange has determined that Wesana Health Holdings Inc. (the "Issuer") has not met the continued listing requirements as set out... ► Artikel lesen | |
05.07.23 | Lucy Scientific Discovery. Inc.: Lucy Scientific Discovery, Inc. Achieves Major Milestone with Successful Completion of its Acquisition of the Assets of Wesana Health | 409 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, July 05, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. ("Lucy" or "the Company") (NASDAQ: LSDI) proudly announces the successful completion of its acquisition... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS MEDICAL CARE | 39,980 | -0,55 % | Aixtron, FMC, LPKF Laser, ProSiebenSat.1 Media, Siemens Energy, Varta und Co. - Aktien-Positionen der Shortseller | Wer Aktien leer verkauft, das sogenannte Shortselling, muss Transparenzpflichten erfüllen. Wir werfen einen Blick auf aktuelle Shortseller-Meldungen. Geregelt sind diese in der EU-Leerverkaufsverordnung... ► Artikel lesen | |
ESSILORLUXOTTICA | 202,20 | +0,35 % | Minimaler Kursabschlag bei der EssilorLuxottica SA-Aktie (203,20 €) | Wenig Kursbewegung gegenwärtig bei der EssilorLuxottica SA-Aktie . Das Wertpapier notiert zur Stunde bei 203,20 Euro. Die Wertschätzung der Börsenteilnehmer für die EssilorLuxottica SA-Aktie hat sich... ► Artikel lesen | |
SERNOVA | 0,283 | +1,87 % | Sernova Corp: Sernova talks AGM voting results | ||
ALIGN TECHNOLOGY | 268,20 | +0,37 % | Q&M Dental Group Ltd: Q&M Dental Enhances its Digital Capabilities by Integrating Align Technology's Newest iTero Lumina Intraoral Scanner Across Dental Clinics in Singapore | SINGAPORE, Apr 29, 2024 - (ACN Newswire) - Mainboard listed Q&M Dental Group (Singapore) Limited ("Q&M" or "the Company" and together with its subsidiaries, the "Group") is proud to announce its integration... ► Artikel lesen | |
NUGEN MEDICAL DEVICES | 0,070 | -1,13 % | Nugen Medical Devices Inc: Nugen Medical two million shares for debt | ||
INMODE | 16,535 | +2,19 % | InMode LTD: InMode Reports First Quarter 2024 Financial Results; Quarterly Revenue of $80.3M Represents 24% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet available) of $96M | Company Announces Share Repurchase Program of Up to 8.37 Million Shares; and
Appoints New Chairman of the Board of Directors
YOKNEAM, Israel, May 2, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD)... ► Artikel lesen | |
INVITAE | 0,110 | 0,00 % | Invitae Corp - 8-K, Current Report | ||
ATOSSA THERAPEUTICS | 1,448 | +1,83 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (ADCs) and (Z)-Endoxifen | SEATTLE, April 29, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company") today announced an expanded research agreement with Weill Cornell Medicine to explore... ► Artikel lesen | |
SPINEWAY | 0,680 | +0,59 % | SPINEWAY: Growth of 28% of 2024 first quarter revenue | Press release Ecully, April 16, 2024 - 8 p.m. First-quarter 2024 revenue of €3.1 million Growth of 28% compared with 2023 first quarter In thousands of euros20242023Change 2023/2022Q1 revenue3... ► Artikel lesen | |
MOUNTAIN VALLEY MD | 0,039 | -1,01 % | Mountain Valley MD Holdings Inc: Mountain Valley licenses Agrarius plant signalling tech | ||
ELEVANCE HEALTH | 491,90 | +0,39 % | Kaum Impulse für die Elevance Health-Aktie (503,2196 €) | Am US-amerikanischen Aktienmarkt ist das Wertpapier von Elevance Health aktuell unauffällig. Der jüngste Kurs betrug 538,45 US-Dollar. Wenig getan hat sich heute bislang beim Kurs von Elevance Health.... ► Artikel lesen | |
INVIVO THERAPEUTICS HOLDINGS | 0,310 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.02.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 23.02.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.02.2024.ISIN NameCA58503M4083 MEDIVOLVE... ► Artikel lesen | |
HEALWELL AI | 1,090 | +1,87 % | WELL Health lanciert die zweite Generation seines KI-gestützten Co-Piloten auf Basis der Technologie von HEALWELL Health AI, der Ärzten die Erkennung von chronischen Erkrankungen erleichtert | - WELL
und HEALWELL AI haben die zweite Generation ihres "WELL AI Decision Support"-Tools ("WAIDS") auf den Markt gebracht, das nun auch ein erweitertes Screening auf chronische Krankheiten... ► Artikel lesen | |
ONTRAK | 0,237 | -4,05 % | Delisting of Securities of Genesis Growth Tech Acquisition Corp.; Financial Strategies Acquisition Corp.; Kiromic BioPharma, Inc.; Infinity Pharmaceuticals, Inc.; Molekule Group, Inc.; EBET, Inc.; Shift Technologies, Inc.; Ontrak, Inc.; RVL Pharmaceutical | NEW YORK, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the securities of Genesis Growth Tech Acquisition Corp. Genesis Growth Tech Acquisition Corp.'s... ► Artikel lesen | |
VERU | 1,554 | +1,90 % | Veru Inc.: Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss | -- The Phase 2b study planned to be conducted in 15 clinical sites in the United States -- -- Topline clinical data expected in the fourth quarter calendar year 2024 -- MIAMI, FL, April 30, 2024... ► Artikel lesen |